245 related articles for article (PubMed ID: 29469190)
1. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
2. Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.
Zhou LH; Luo XF
Clin Chim Acta; 2017 Nov; 474():102-107. PubMed ID: 28903023
[TBL] [Abstract][Full Text] [Related]
3. The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis.
Ma XM; Sun X; Yang GW; Yu MW; Zhang GL; Yu J; Zhang Y; Wang XM
Climacteric; 2017 Oct; 20(5):448-455. PubMed ID: 28569074
[TBL] [Abstract][Full Text] [Related]
4. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Platelet-to-Lymphocyte Ratio in Cholangiocarcinoma: A Meta-Analysis.
Hu G; Liu Q; Ma JY; Liu CY
Biomed Res Int; 2018; 2018():7375169. PubMed ID: 30539019
[TBL] [Abstract][Full Text] [Related]
6. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
7. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies.
Zhao Z; Zhao X; Lu J; Xue J; Liu P; Mao H
Arch Gynecol Obstet; 2018 Apr; 297(4):849-857. PubMed ID: 29368160
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review.
Zhu Y; Zhou S; Liu Y; Zhai L; Sun X
BMC Cancer; 2018 Apr; 18(1):443. PubMed ID: 29669528
[TBL] [Abstract][Full Text] [Related]
10. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.
Zhang WW; Liu KJ; Hu GL; Liang WJ
Tumour Biol; 2015 Nov; 36(11):8831-7. PubMed ID: 26063409
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
13. Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.
Song W; Tian C; Wang K; Zhang RJ; Zou SB
PLoS One; 2017; 12(6):e0178762. PubMed ID: 28575033
[TBL] [Abstract][Full Text] [Related]
14. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
15. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
Ma JY; Ke LC; Liu Q
Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
[TBL] [Abstract][Full Text] [Related]
16. Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis.
Li B; Zhou P; Liu Y; Wei H; Yang X; Chen T; Xiao J
Clin Chim Acta; 2018 Aug; 483():48-56. PubMed ID: 29678631
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.
Gu X; Sun S; Gao XS; Xiong W; Qin S; Qi X; Ma M; Li X; Zhou D; Wang W; Yu H
Sci Rep; 2016 Mar; 6():23893. PubMed ID: 27025911
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis.
Zhang F; Gong W
Front Oncol; 2020; 10():1116. PubMed ID: 32850320
[No Abstract] [Full Text] [Related]
19. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.
Li DY; Hao XY; Ma TM; Dai HX; Song YS
Sci Rep; 2017 Nov; 7(1):15387. PubMed ID: 29133845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
